Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study

被引：0
|
作者：
Qinqin Zhao
Bei Zheng
Bing Han
Pinpin Feng
Zhongni Xia
Hong Jiang
Yin Ying
Jun Zhu
Cheng Fei
Junlei Xiang
Lingli Shen
Qiliang Luo
Yinhuan Wu
Ayiguzhali Wusiman
Chuanwei Xin
Meiling Zhang
Gonghua Li
Xiang Li
机构：
[1] Tongde Hospital of Zhejiang Province,Department of Pharmacy
[2] The 72nd Group Army Hospital of PLA,Department of Pharmacy
[3] Longquan People’s Hospital,Department of Pharmacy
[4] Linping Hospital of Integrated Traditional Chinese and Western Medicine,Department of Pharmacy
[5] Zhaotong Mental Health Center,Department of Pharmacy
[6] Ruian Fifth People’s Hospital,Department of Pharmacy
[7] Fourth People’s Hospital of Aksu Region,Department of Pharmacy
[8] Hangzhou Medical College,School of Basic Medical Sciences and Forensic Medicine
来源：
Infectious Diseases and Therapy | 2023年 / 12卷
关键词：
COVID-19; Azvudine; Nirmatrelvir-ritonavir; Real-world; Clinical outcome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2087 / 2102
页数：15
相关论文
共 50 条
  • [21] Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China
    Shang, Nan
    Li, Xianlin
    Guo, Zhiyu
    Zhang, Lan
    Wang, Shanshan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial
    Zhou, Yiling
    Liu, Yi
    Jiang, Li
    Zhang, Renqing
    Zhang, Huohuo
    Shi, Qingyang
    Yang, Zhirong
    Mao, Yi
    Liu, Sha
    Yang, Zhibo
    Ding, Jialin
    Zhou, Yongzhao
    Ren, Bi
    He, Liping
    Zhao, Xing
    Li, Weimin
    Li, Sheyu
    Liu, Dan
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (12)
  • [23] Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation
    Kwok, Wang Chun
    Tam, Terence Chi Chun
    Ho, James Chung Man
    Lam, David Chi Leung
    Ip, Mary Sau-Man
    Ho, Pak Leung
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 77 - 86
  • [24] Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World Study
    Sun, Ranran
    Wang, Haiyu
    Sun, Junyi
    Yang, Mengzhao
    Zhang, Shixi
    Hu, Xinjun
    Yu, Bo
    Song, Zhan
    Han, Na
    Luo, Hong
    Cheng, Ming
    Li, Guangming
    Li, Guotao
    Yuan, Yiqiang
    Liang, Lili
    Zhang, Yanyang
    Zhang, Donghua
    Li, Silin
    Kan, Quancheng
    Liang, Hongxia
    Ren, Zhigang
    ADVANCED SCIENCE, 2025,
  • [25] Efficacy and Safety of Nirmatrelvir/Ritonavir in Severe Hospitalized Patients with COVID-19 and in Patients at High Risk for Progression to Critical Illness: A Real-World Study
    Chen, Xiaohua
    Zhu, Ying
    Shen, Leer
    Zhou, Dan
    Feng, Nannan
    Tong, Qiang
    JOURNAL OF INTENSIVE CARE MEDICINE, 2024, 39 (08) : 742 - 750
  • [26] Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 Response
    Wan, Eric Yuk Fai
    Yan, Vincent Ka Chun
    Mok, Anna Hoi Ying
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (10) : eL230265
  • [27] Nirmatrelvir-Ritonavir Reduced Mortality in Hospitalized Patients with COVID-19 During the Omicron Outbreak: Real-World Evidence from Beijing
    Zhang, Yi
    Wang, Xinrui
    Huang, Chong
    Yang, Hui
    Jiang, Chunguo
    Yu, Xiaojia
    Hong, Jun
    Zhang, Yi
    Wang, Yushu
    Zhao, Rui
    An, Zhuoling
    Tong, Zhaohui
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 1367 - 1377
  • [28] Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients
    Kim, Min-Kyung
    Lee, Kyung-Shin
    Ham, Sin Young
    Choi, Youn Young
    Lee, Eunyoung
    Lee, Seungjae
    Lee, Bora
    Jeon, Jaehyun
    Chin, Bumsik
    Kim, Yeonjae
    Kim, Gayeon
    Jang, Hee -Chang
    Choi, Jae-Phil
    Park, Sang -Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (35)
  • [29] Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients
    Zaharuddin, Zahirah
    Hussin, Nur Sabiha Md
    Karuppannan, Mahmathi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19
    LeBras, Marlys
    Crawley, Alex
    Legge, Marc
    Takaya, Satchan
    Lee, Stephen
    Regier, Loren
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (08) : 546 - 549
12345